The right clinical trial tech stack isn’t the most complete one; it’s the one built with sites, funded fairly, and designed to remove friction, not add it.
- The Risks And Unresolved Rules Of Real-Time Clinical Trials
- What Real-Time Clinical Trials Demand From Your Tech Stack
- The FDA's RTCT Push: What It Is; Why It Matters
- Pharma's Digital Transformation: Where It's Really At
- How AI Is Changing Clinical Trial Design, Not Just Speed
- What Is Clinical Trials Day? Why Technology Helps Research Rise
- DiMe's Navigator: Why Teams Still Stall On Digital Endpoints
- Why Are Life Science Companies So Poorly Prepared For RIM's Future?
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Implementing eSource: A Guide For Operations And Technology Roles
By recognizing and addressing the challenges associated with eSource integration, research facilities can fully harness its transformative potential, optimizing efficiency and reliability.
-
Elevating Rater Training For More Reliable Study Outcomes
Well-trained raters are key to generating high-quality, consistent clinical trial data. Explore a program offering customized training tailored to the experience levels of raters.
-
How MAC Clinical Research Innovates With CDMS/EDC
Discover how a partnership with one of Europe’s largest contract research organizations exemplifies the crucial role that technology plays in the realm of clinical studies.
-
FDA Releases Updated Draft Guidance On Decentralized Clinical Trials
Take a closer look at the FDA's draft guidance on designing and implementing DCTs, notably remote trial visits, the use of digital health technologies, institutional review board oversight, and more.
-
How FAIR Data Principles Deliver Clinical Success
Prioritize data management that adheres to FAIR principles — findable, accessible, interoperable, and reusable — to gain operational insights that enable quick decisions and ensure participant well-being.
-
Feasibility Insights In HR+/HER2 - Metastatic Breast Cancer
This case study showcases how advanced analytics were used to streamline feasibility planning for a Phase II clinical trial targeting HR+/HER2- metastatic breast cancer as a second-line treatment.
-
Vendor Selection Bias: Why Structured Decisions Often Fail
Learn how subtle influences derail decisions and discover proven safeguards that promote transparency, accountability, and shared ownership for better trial outcomes.
-
Key Insights From The FDA's DHT Guidance
Check out a summary of the FDA’s guidance Framework for the Use of DHTs in Clinical Trials and what it means for sponsors and investigators using these innovative tools.
-
QT Monitoring Impacts More Than Just Cardiac Health
Achieve earlier detection of potential adverse cardiac events and refine patient selection for future trial phases by implementing advanced QT monitoring tools.
-
The Crucial Role Of IRT/RTSM In Optimizing Drug Supply Budgets
Expand your knowledge of IRT/RTSM systems and their capabilities to tailor supplies to site-specific recruitment, significantly decrease drug waste and costs, ensure efficient IMP management, and more.
RECENT NEWSLETTERS
- 06.06.26 -- Best Of May: AI Risk, CRO Strategy, And Trial Cost Control
- 06.04.26 -- Why Clinical Execution — Not Tech — Is Trials' Biggest Risk
- 05.28.26 -- FDA's Elsa AI Shift, RTCT Rules, And RWE That Works
- 05.21.26 -- AI, HEOR, And Hidden Costs Reshaping Clinical Trials
- 05.14.26 -- AI, RWE, And The Systems Breaking Clinical Trials